Medical cannabis under the microscope: 1,000 patients tracked for Real-World relief

NCT ID NCT04526093

First seen Jun 26, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This study follows 1,000 adults in Canada who are authorized to use medical cannabis for pain, sleep issues, anxiety, depression, or epilepsy. Researchers will track changes in symptoms using standard questionnaires over 24 weeks. The goal is to see how well medical cannabis works in everyday life, outside a lab setting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Medical cannabis (medical marijuana)
What this could lead to
If successful, this could provide real-world evidence on whether medical cannabis effectively eases pain, improves sleep, and reduces anxiety or depression symptoms.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by other factors. It also relies on patient reports, which can be subjective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Toronto General Hospital, UHN

    RECRUITING

    Toronto, Ontario, M5G 2C4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.